Home » Topics » Conferences

Conferences
RSS

NCI scientists evaluate MMP inhibitor from CollaGenex

March 23, 1999

Another anticoagulant series presented by DuPont at the ACS meeting

March 23, 1999

Calpain I inhibitors designed at Cephalon show neuroprotective activity in animal model

March 23, 1999

ACS highlights: design of new antitumor agents based on computer models of tubulin structure

March 23, 1999

Lilly reports initial clinical data for LY-333531

March 23, 1999

New thioureas: synthesis and apoptosis induction

March 23, 1999

SLV-307, a compound with dual dopaminergic and serotonergic effects in humans

March 23, 1999

SB-247083: design of a selective, orally active ETA antagonist

March 23, 1999

Positive phase I results reported for Il Yang's proton pump inhibitor

March 23, 1999

ABT-627 now being evaluated in humans

March 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.